Vitrue Health operates a digital musculoskeletal (MSK) health platform for workplaces that uses computer vision and biomechanical analysis to deliver workplace health assessments that are accurate, holistic and personalised. The platform aims to reduce musculoskeletal pain and help employers fulfil regulatory obligations at scale. It is used by customers including Bupa, the NHS, Hastings Direct and Campari. Led by CEO Shane Lowe, the London-based technology startup specialises in reducing musculoskeletal pain and supporting workplace health. The company raised $4M in a recent funding round, bringing its total funding to $7M. Vitrue plans to use the proceeds to grow the team and advance expansion across the US and into new European markets.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2024